On August 26, 2025 Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, reported that management will participate and be available for one-on-one meetings at the following investor conferences (Press release, Altimmune, AUG 26, 2025, View Source [SID1234655489]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Wells Fargo Healthcare Conference in Boston, MA
Friday, September 5, 2025
One-on-one meetings only
H.C. Wainwright Global Investment Conference in New York, NY
Tuesday, September 9, 2025
Fireside chat at 8:30 a.m. Eastern Time
The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.
Morgan Stanley Global Healthcare Conference in New York, NY
Wednesday, September 10, 2025
Fireside chat at 7:45 a.m. Eastern Time
The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.